The Global Contraceptive Drugs and Devices Market is expected to increase at a higher rate by 2027 expanding at a reasonable CAGR during the forecast period (2021-2027). Contraception is the use of various agents, drugs, devices, and surgical procedures for the prevention of unwanted pregnancy.
For a detailed analysis of the Contraceptive Drugs and Devices Market browse through https://univdatos.com/report/contraceptive-drugs-and-devices-market-current-analysis-and-forecast-2021-2027
A rise in the number of unintended pregnancies, Sexually Transmitted Diseases (STD) cases, and increased Government initiatives is driving the adoption and penetration of contraceptive drugs and devices globally. Rising awareness regarding contraceptive pills further drives the market growth. Female sterilization is the most common contraceptive method used among women worldwide. In 2019, 23.7% or 219 million women are currently using contraception. Male condom (189 million), IUD (159 million) and pill (151 million) were the other three majorly used method for the prevention of unwanted pregnancy. A contraceptive pill or birth control pill mainly contains hormones such as progestin and estrogen which block the release of eggs or ova from the female ovaries. Hence, no fertilization occurs. There are several benefits associated with contraceptive pills beyond the prevention of pregnancy such as less pain, clear skin, prevention of ovarian cyst, and regular menstrual cycle.
For a detailed analysis of the market drivers in Contraceptive Drugs and Devices Market browse through
COVID-19 have a wide impact on Contraceptive Drugs and Devices market growth. This is majorly due to the lack of access to contraceptives. As per WHO, due to COVID-19, 7 in 10 countries have disrupted health services in contraception and family planning. There is a huge disruption in the manufacturing and supply chain of contraceptive pills which is leading to a decline in the market growth. As per United Nations Population Fund (UNFPA), there will be stock outs of various contraceptive drugs and devices including oral contraceptive pills, condoms, copper intrauterine devices (IUDs), and depot medroxyprogesterone acetate (DMPA).
For a detailed analysis of the COVID-19 Impact on Contraceptive Drugs and Devices Market browse through
Based on Products, the market is fragmented into Drugs and Devices. Based on drugs the global Contraceptive drugs and devices market is bifurcated into Oral Contraceptives, Topical Contraceptives and Contraceptive Injectable. Contraceptive Devices are bifurcated into Condoms, Diaphragms, Cervical Caps, Sponges Vaginal Rings, and IUD. Within the Contraceptive drugs market, oral contraceptives hold the major share due to their high efficacy, ease to intake, easy availability, and inexpensive. In terms of Devices, condoms are mainly used owing to increase cases of unwanted pregnancies, increase cases of STDs, and an increase in initiatives taken by the government. Based on Gender, the market is divided into Male and Female. The Male subsegment grabbed the major market owing to the increase in commercialization of male birth control Devices such as contraceptive injection for men. The female subsegment is also expected to witness high growth owing to an increasing unwanted pregnancy.
For a detailed analysis of the technology in Contraceptive Drugs and Devices Market browse through
Based on the distribution channel, the market is segmented into Hospital & Clinics, Retail Pharmacy, Online Pharmacy, and Others. The retail pharmacy is expected to be the fastest-growing market owing to an increase in over-the-counter purchasing of contraceptive drugs. a detailed analysis was conducted for different regions and countries including North America (US, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, UK, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of APAC), Rest of World. In Eastern and South-Eastern Asia, IUD 18.6% is the most common contraceptive method used, compared pill 17.8% and male condom 14.6% in the Europe and Northern America region.
Some of the major players operating in the market include Bayer AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Mylan N.V., Allergan Plc, Agile Therapeutics, Piramal Enterprises Ltd., GlaxoSmithKline PLC, Johnson & Johnson, Novartis AG, and Sanofi, etc. Several M&As along with partnerships have been undertaken by these players to boost their presence in different regions.
Global Contraceptive Drugs and Devices Market Segmentation
Market Insight, by Products
Market Insight, by Gender
Market Insight, by Distribution Channel
Market Insight, by Region